An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in quality health care accountability and protection, further providing for medical policies and clinical review criteria.

This bill amends Pennsylvania's Insurance Company Law to require health insurers and managed care plans to include specific clinical review criteria in their medical policies. The key provision mandates that these policies cannot exclude, restrict, or delay coverage for prescription drugs solely because they received expedited FDA approval for serious or life-threatening conditions. Directly affecting insurance companies and managed care organizations, the law aims to ensure access to newly approved treatments without artificial barriers based on the speed of regulatory approval. The changes become effective 60 days after the bill is enacted.